Keywords: class, action, against, w-l, over, rezulin, lawyers
Class action against W-L over Rezulin
Article | 31 March 2000
Lawyers representing users of the antidiabetic Rezulin (troglitazone)have filed the first US nationwide class action suit against Warner-Lambert, charging ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
